Article Name Artificial Intelligence
Generative artificial intelligence (GenAI) is reshaping how the medical technology (MedTech) sector operates. As healthcare systems worldwide grapple with increasing demands for precision, efficiency, and personalization, GenAI is a pivotal force that modernizes diagnostics, treatment plans, and patient outcomes. The potential of Generative AI in healthcare is staggering, projected to outpace its growth in any other industry. With a compound annual growth rate of 85% through 2027, GenAI is set to transform various functions in healthcare, including diagnostics, personalized care, research and development (R&D), and software development.
30th October, 2024
The collaboration aims to expand access to AI across Asia-Pacific, enhancing diagnostic detection and improving patient outcomes
29th October, 2024
To accelerate and transform NHS adoption of radiology AI
24th October, 2024
AI-Ready Platform Helps Healthcare Organizations Reduce Cyber Risk, Enhance User Experience, and Simplify IT Infrastructure in the Face of Growing Data Breach Costs
25th October, 2024
A comprehensive genomic test for cancer patients
21st October, 2024
Innovations include Health Companion research project powered by agentic AI
21st October, 2024
Neurophet's brain MRI analysis technology incorporates fluid biomarker data from AriBio's global Phase 3 clinical trial for Alzheimer's disease
16th October, 2024
For people living with Alzheimer’s and dementia
15th October, 2024
Simplifying workflow and deliver high-quality care
14th October, 2024
Health Ministry is injecting about $200 million over five years into the Health Innovation Fund
14th October, 2024
“Precise and timely detection of lung and breast cancer with enhanced diagnosis accuracy, efficient workflow can eliminate treatment delays and improve survival rates” explains Dr Anthony Lawrence, GE HealthCare's Chief Marketing and Strategy Officer for ASEAN, Korea and Australia and New Zealand (AKA) region.
10th October, 2024
Collaboration with Blackford provides new AI-enabled offerings helping radiologists in faster diagnosis, treatment
09th October, 2024
Philips intends to introduce its cutting-edge AI technologies into Siloam Hospitals
07th October, 2024
To secure FDA De Novo approval by 2025, with plans to launch product in the United States shortly thereafter
29th September, 2024
First product to deliver arrhythmia monitoring service utilising Artificial Intelligence
17th September, 2024
See-Mode's AI solution aims to reduce reporting time and variation in delivery of care for thyroid ultrasound
17th September, 2024
Qritive's AI-powered solutions to be fully integrated with Roche navify Digital Pathology platform
13th September, 2024
To enable rapid delivery of treatment to patients
03rd September, 2024
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer